Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound lithospermum oil is an infused or extracted oil preparation derived from the roots of Lithospermum erythrorhizon (commonly known as purple gromwell or redroot gromwell), a plant used in traditional Asian medicine. The main active components are shikonin and β,β-dimethylacryloyl alkannin, which have demonstrated anti-inflammatory, antibacterial, wound-healing, and antioxidant properties. Compound lithospermum oil is primarily used topically for skin conditions such as eczema, psoriasis, dermatitis, burns, cuts, rashes, hives and acne. It soothes inflammation and redness by promoting keratinocyte apoptosis (cell death), inhibiting keratinocyte proliferation and angiogenesis (formation of new blood vessels), blocking the cell cycle in skin cells involved in inflammatory processes and supporting skin barrier function. It also has moisturizing effects on human skin[1][4][5][6][7]. The product is widely used in personal care products for its ability to hydrate the skin and support healing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on compound lithospermum oil.